-
Asselah T, 2012: A revolution in hcv treatment with direct-acting antivirals: from non-response to eradication[J]. J Hepatol, 57, 455-457.
-
Bashirova AA, Martin MP, McVicar DW, Carrington M, 2006: The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense[J]. Annu Rev Genomics Hum Genet, 7, 277-300. doi: 10.1146/annurev.genom.7.080505.115726
-
Bunce M, O'Neill CM, Barnardo MC, Krausa P, Browning MJ, Morris PJ, Welsh KI, 1995: Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP)[J]. Tissue Antigens, 46, 355-367. doi: 10.1111/tan.1995.46.issue-5
-
Carneiro VL, Lemaire DC, Bendicho MT, Souza SL, Cavalcante LN, Angelo AL, Freire SM, Mendes CM, Santana N, Lyra LG, Lyra AC, 2010: Natural killer cell receptor and HLA-C gene polymorphisms among patients with hepatitis C: a comparison between sustained virological responders and non-responders[J]. Liver Int, 30, 567-573. doi: 10.1111/liv.2010.30.issue-4
-
Chinese Society of Hepatology CMA , Wei L, Chinese Society of Infectious Diseases CMA , Hou JL, 2015: The guideline of prevention and treatment for hepatitis C: a 2015 update[J]. Zhonghua Gan Zang Bing Za Zhi, 23, 906-923.
-
de Vasconcelos JM, de Jesus Maues Pereira Moia L, Amaral IS, Miranda EC, Cicalisetakeshita LY, de Oliveira LF, de Araujo Melo Mendes L, Sastre D, Tamegao-Lopes BP, de Aquino Pedroza LS, Batista Dos Santos SE, Soares MC, de Araujo MT, Bandeira CL, de Sousa da Silva AM, de Medeiros ZL, Sena L, Demachki S, Dos Santos EJ, 2013: Association of killer cell immunoglobulin-like receptor polymorphisms with chronic hepatitis c and responses to therapy in Brazil[J]. Genet Mol Biol, 36, 22-27. doi: 10.1590/S1415-47572013000100004
-
Dring MM, Morrison MH, McSharry BP, Guinan KJ, Hagan R, Irish HCVRC, O'Farrelly C, Gardiner CM, 2011: Innate immune genes synergize to predict increased risk of chronic disease in hepatitis C virus infection[J]. Proc Natl Acad Sci U S A, 108, 5736-5741. doi: 10.1073/pnas.1016358108
-
Du Z, Gjertson DW, Reed EF, Rajalingam R, 2007: Receptor-ligand analyses define minimal killer cell ig-like receptor (KIR) in humans[J]. Immunogenetics, 59, 1-15.
-
Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales FL Jr, Haussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J, 2002: Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection[J]. N Engl J Med, 347, 975-982. doi: 10.1056/NEJMoa020047
-
Gebo KA, Bartlett JG, 2002: Management of hepatitis C: a review of the NIH consensus development conference[J]. Hopkins HIV Rep, 14, 1-4.
-
Hsu KC, Liu XR, Selvakumar A, Mickelson E, O'Reilly RJ, Dupont B, 2002: Killer ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets[J]. J Immunol, 169, 5118-5129. doi: 10.4049/jimmunol.169.9.5118
-
Parham P, 2005: MHC class Ⅰ molecules and KIRs in human history, health and survival[J]. Nat Rev Immunol, 5, 201-214. doi: 10.1038/nri1570
-
Robinson J, Waller MJ, Parham P, de Groot N, Bontrop R, Kennedy LJ, Stoehr P, Marsh SG, 2003: IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex[J]. Nucleic Acids Res, 31, 311-314. doi: 10.1093/nar/gkg070
-
Single RM, Martin MP, Gao X, Meyer D, Yeager M, Kidd JR, Kidd KK, Carrington M, 2007: Global diversity and evidence for coevolution of KIR and HLA[J]. Nat Genet, 39, 1114-1119. doi: 10.1038/ng2077
-
Vidal-Castineira JR, Lopez-Vazquez A, Diaz-Pena R, Alonso-Arias R, Martinez-Borra J, Perez R, Fernandez-Suarez J, Melon S, Prieto J, Rodrigo L, Lopez-Larrea C, 2010: Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection[J]. J Virol, 84, 475-481. doi: 10.1128/JVI.01285-09
-
Vidal-Castineira JR, Lopez-Vazquez A, Martinez-Borra J, Martinez-Camblor P, Prieto J, Lopez-Rodriguez R, Sanz-Cameno P, de la Vega J, Rodrigo L, Perez-Lopez R, Perez-Alvarez R, Lopez-Larrea C, 2014: Diversity of killer cell immunoglobulin-like receptor (KIR) genotypes and KIR2DL2/3 variants in HCV treatment outcome[J]. PLoS ONE, 9, e99426-. doi: 10.1371/journal.pone.0099426
-
Zwolinska K, Blachowicz O, Tomczyk T, Knysz B, Gasiorowski J, Zalewska M, Orzechowska BU, Sochocka M, Piasecki E, 2016: The effects of killer cell immunoglobulin-like receptor (KIR) genes on susceptibility to HIV-1 infection in the polish population[J]. Immunogenetics, 68, 327-337. doi: 10.1007/s00251-016-0906-1